Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Rini

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Oncology|April 18, 2001
An update on prostate cancerB I Rini, E J Small
Current Oncology Reports|August 8, 2001
Immunotherapy for prostate cancerB I Rini, E J Small
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotideB I Rini, T F Gajewski
Seminars in Oncology|April 18, 2000
Prognostic factors in renal carcinomaB I Rini, N J Vogelzang
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2015
Alternate sunitinib schedules in patients with metastatic renal cell carcinomaS Kalra, B I Rini, E Jonasch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesionsB I Rini, L M Selk, N J Vogelzang
The Journal of Urology|March 21, 2001
Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinomaB I Rini, T M Zimmerman, T F Gajewski, et al.
Cancer|April 7, 1998
Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trialB I Rini, W M Stadler, R T Spielberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinomaC M George, N J Vogelzang, B I Rini, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2014
A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinomaY G Najjar, K Mittal, P Elson, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|April 18, 2001
An update on prostate cancerB I Rini, E J Small
Current Oncology Reports|August 8, 2001
Immunotherapy for prostate cancerB I Rini, E J Small
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotideB I Rini, T F Gajewski
Seminars in Oncology|April 18, 2000
Prognostic factors in renal carcinomaB I Rini, N J Vogelzang
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2015
Alternate sunitinib schedules in patients with metastatic renal cell carcinomaS Kalra, B I Rini, E Jonasch
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesionsB I Rini, L M Selk, N J Vogelzang
The Journal of Urology|March 21, 2001
Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinomaB I Rini, T M Zimmerman, T F Gajewski, et al.
Cancer|April 7, 1998
Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trialB I Rini, W M Stadler, R T Spielberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinomaC M George, N J Vogelzang, B I Rini, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2014
A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinomaY G Najjar, K Mittal, P Elson, et al.
Pageof 4